Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retroperitoneal radical hysterectomy

G Delgado1, R K Potkul, J R Dolan

  • 1Department of Obstetrics and Gynecology, Loyola University of Chicago, Maywood, Illinois 60153, USA.

Gynecologic Oncology
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fungal Planet description sheets: 1697-1780.

Fungal systematics and evolution·2025
Same author

Fungal Planet description sheets: 1614-1696.

Fungal systematics and evolution·2024
Same author

Fungal Planet description sheets: 1550-1613.

Persoonia·2024
Same author

Fungal Planet description sheets: 1478-1549.

Persoonia·2024
Same author

Fungal Planet description sheets: 1383-1435.

Persoonia·2024
Same author

Fungal Planet description sheets: 1182-1283.

Persoonia·2022
Same journal

Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.

Gynecologic oncology·2026
Same journal

Adjunctive sodium-glucose cotransporter 2 (SGLT2) inhibitors with progestins and endometrial cancer risk in benign uterine diseases and hyperplasia.

Gynecologic oncology·2026
Same journal

Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.

Gynecologic oncology·2026
Same journal

PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

Gynecologic oncology·2026
Same journal

A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancer.

Gynecologic oncology·2026
Same journal

Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

Gynecologic oncology·2026
See all related articles

A novel retroperitoneal radical hysterectomy technique offers a less invasive approach for cervical cancer. This modified procedure reduces operative time and hospital stay, demonstrating promising outcomes for early-stage patients.

Area of Science:

  • Gynecologic Oncology
  • Surgical Innovation
  • Minimally Invasive Surgery

Background:

  • Radical hysterectomy is a standard treatment for early-stage cervical cancer.
  • Traditional approaches can involve significant morbidity and prolonged recovery.
  • There is a need for refined surgical techniques to improve patient outcomes.

Purpose of the Study:

  • To present a modified retroperitoneal radical hysterectomy technique.
  • To evaluate the feasibility, safety, and preliminary outcomes of this new approach.
  • To compare its benefits against established surgical methods.

Main Methods:

  • A novel retroperitoneal approach combining abdominal and vaginal techniques was developed.
  • The procedure involves small skin incisions superior to the inguinal ligament for retroperitoneal access.

Related Experiment Videos

  • Key structures are divided without entering the peritoneal cavity, followed by a modified Schauta technique.

    • Main Results:

    • Eight patients with Stage I cervical cancer underwent the retroperitoneal radical hysterectomy.
    • Expected operative time is 3.5-4 hours with blood loss comparable to the Meigs procedure.
    • Patients experienced minimal discomfort, with hospital stays of 4 days or less.
    • One patient was discharged on the same day; bladder atony was the main complication.

    Conclusions:

    • The retroperitoneal radical hysterectomy is a safe and effective alternative for early-stage cervical cancer.
    • This technique potentially reduces operative time and hospital stay compared to traditional methods.
    • It utilizes conventional surgical skills while maintaining the principles of radical abdominal hysterectomy.